Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
BJPsych Open ; 10(3): e106, 2024 May 09.
Article in English | MEDLINE | ID: mdl-38721787

ABSTRACT

BACKGROUND: Few previous studies have established Snaith-Hamilton Pleasure Scale (SHAPS) cut-off values using receiver operating characteristic curve analysis and applied these values to compare predictors of anhedonia between clinical and nonclinical groups. AIMS: To determine the optimal cut-off values for the SHAPS and use them to identify predictors of anhedonia in clinical and nonclinical groups in Taiwan. METHOD: This cross-sectional and correlational study used convenience sampling to recruit 160 patients from three hospitals and 412 students from two universities in northern Taiwan. Data analysis included receiver operating characteristic curve, univariate and multivariate analyses. RESULTS: The optimal SHAPS cut-off values were 29.5 and 23.5 for the clinical and nonclinical groups, respectively. Moreover, two-stage analysis revealed that participants in the clinical group who perceived themselves as nondepressed, and participants in the nonclinical group who did not skip classes and whose fathers exhibited higher levels of care and protection were less likely to attain the cut-off values. Conversely, participants in the nonclinical group who reported lower academic satisfaction and were unwilling to seek help from family or friends were more likely to attain the cut-off values. CONCLUSIONS: Our findings highlight the importance of optimal cut-off values in screening for depression risk within clinical and nonclinical groups. Accordingly, the development of comprehensive, individualised programmes to monitor variation trends in SHAPS scores and relevant predictors of anhedonia across different target populations is crucial.

2.
Clin EEG Neurosci ; 54(3): 215-223, 2023 May.
Article in English | MEDLINE | ID: mdl-35491557

ABSTRACT

Objectives. Microstate studies of electroencephalograms (EEGs) on schizophrenia (SCZ) and bipolar disorder (BD) demonstrated categorical differences. The relationship between microstate indices and clinical symptoms in each group, however, remained unclear. Our objective was to examine associations between EEG microstates and the core features of SCZ and BD. Methods. This study examined the resting EEG data of 40 patients with SCZ, 19 patients with BD (12 BD type I and 7 BD type II), and 16 healthy controls. EEG topographic maps were divided into four canonical microstate classes: A, B, C, and D. The Positive and Negative Syndrome Scale (PANSS), Young Mania Rating Scale, Hamilton Depression Rating Scale (HAMD), and Global Assessment of Functioning (GAF) were used to measure clinical symptoms and global functioning. Results. There was a significant inverse correlation between the proportion of time spent in microstate class A and GAF in patients with SCZ but not BD. Furthermore, the occurrence of microstate class A was positively correlated with the Positive Scale scores of the PANSS. Nevertheless, there were no group differences between the microstate classes. Conclusions. The results of this study indicate a negative correlation between microstate class A and global functioning in SCZ but not in BD. The association may be mediated by positive symptoms of SZ. Neural mechanisms underlying this relationship require further investigation.


Subject(s)
Bipolar Disorder , Schizophrenia , Humans , Bipolar Disorder/diagnosis , Electroencephalography , Rest , Brain
4.
Psychosom Med ; 81(3): 237-245, 2019 04.
Article in English | MEDLINE | ID: mdl-30652987

ABSTRACT

OBJECTIVE: Anxiety and depression are risk factors for obstructive coronary artery disease (CAD), but their effects on coronary artery spasm (CAS) remain unestablished. METHODS: Patient records in this population-based study were retrospectively collected from the Taiwan National Health Insurance Research Database. Using propensity score matching, we used 1:1:1 ratio stratification into a control group of 10,325 individuals without CAS or CAD, a CAS group comprising 10,473 patients, and a CAD group comprising 10,473 patients during 2000-2012. RESULTS: The prevalence of CAS and CAD was 0.067% and 8.7%, respectively, in the general population. The prevalence of anxiety and depression diagnoses was significantly higher in patients with new-onset CAS than in those with new-onset CAD and controls without CAS/CAD, even after propensity score matching. Compared with CAD, anxiety and depression diagnoses conferred a higher risk of developing CAS (odds ratio [OR] = 2.29, 95% confidence interval [CI], 2.14-2.45, p < .001, and OR = 1.34, 95% CI, 1.08-1.66, p = .007, respectively). The association was even stronger when comparing CAS with the control group without CAD or CAS (OR = 5.20, 95% CI, 4.72-5.74, p < .001, and OR = 1.98, 95% CI, 1.50-2.62, p < .001, respectively). The increased risk of new-onset CAS as related to previous anxiety and depression diagnoses was comparable between males and females. CONCLUSIONS: Compared with CAD or the general population, anxiety and depression diagnoses confer a higher risk of developing CAS. No sex differences are found for the association of anxiety and depression with CAS.


Subject(s)
Anxiety Disorders/epidemiology , Coronary Artery Disease/epidemiology , Depressive Disorder/epidemiology , Spasm/epidemiology , Adult , Aged , Aged, 80 and over , Case-Control Studies , Comorbidity , Databases, Factual , Female , Humans , Male , Middle Aged , Propensity Score , Retrospective Studies , Risk , Taiwan/epidemiology
5.
Schizophr Res ; 188: 63-67, 2017 10.
Article in English | MEDLINE | ID: mdl-28108227

ABSTRACT

Patients with schizophrenia have a higher risk of cardiovascular diseases and higher mortality from them than does the general population; however, the underlying mechanism remains unclear. Impaired cerebral autoregulation is associated with cerebrovascular diseases and their mortality. Increased or decreased cerebral blood flow in different brain regions has been reported in patients with schizophrenia, which implies impaired cerebral autoregulation. This study investigated the cerebral autoregulation in 21 patients with schizophrenia and 23 age- and sex-matched healthy controls. None of the participants had a history of cardiovascular diseases, hypertension, or diabetes. All participants underwent 10-min blood pressure and cerebral blood flow recording through finger plethysmography and Doppler ultrasonography, respectively. Cerebral autoregulation was assessed by analyzing two autoregulation indices: the mean blood pressure and cerebral blood flow correlation coefficient (Mx), and the phase shift between the waveforms of blood pressure and cerebral blood flow determined using transfer function analysis. Compared with the controls, the patients had a significantly higher Mx (0.257 vs. 0.399, p=0.036) and lower phase shift (44.3° vs. 38.7° in the 0.07-0.20Hz frequency band, p=0.019), which indicated impaired maintenance of constant cerebral blood flow and a delayed cerebrovascular autoregulatory response. Impaired cerebral autoregulation may be caused by schizophrenia and may not be an artifact of coexisting medical conditions. The mechanism underlying impaired cerebral autoregulation in schizophrenia and its probable role in the development of cerebrovascular diseases require further investigation.


Subject(s)
Cerebrovascular Circulation , Cerebrovascular Disorders/physiopathology , Homeostasis , Schizophrenia/physiopathology , Adult , Blood Pressure/physiology , Blood Pressure Determination , Brain/blood supply , Brain/diagnostic imaging , Brain/physiopathology , Cerebrovascular Circulation/physiology , Cerebrovascular Disorders/diagnostic imaging , Female , Fingers/blood supply , Fingers/physiopathology , Homeostasis/physiology , Humans , Male , Middle Aged , Pilot Projects , Plethysmography , Schizophrenia/diagnostic imaging , Ultrasonography, Doppler, Transcranial
8.
J Formos Med Assoc ; 109(5): 345-53, 2010 May.
Article in English | MEDLINE | ID: mdl-20497867

ABSTRACT

BACKGROUND/PURPOSE: Information about sex difference is important for the development of better prevention and intervention strategies for geriatric depression. We investigated sex differences in prevalence and risk indicators associated with geriatric depression among community-dwelling elderly people in Shih-Pai, Taipei, Taiwan. METHODS: A cross-sectional community-based survey was conducted from June 1999 to November 2002 among non-institutionalized residents aged =65 years in Shih-Pai community. Trained interviewers collected data through home visits. Geriatric depression was defined as a score of = 5 on the Geriatric Depression Scale-Short Form. RESULTS: The prevalence of geriatric depression was 9.8% in 3970 participants, with a higher rate in women (12.4%) than men (7.8%). Geriatric depression was significantly associated with women [odds ratio (OR) =1.49, 95% confidence interval (CI) =1.07-2.07), separated/divorced marital status (OR =3.29, 95% CI = 1.51-7.18), living alone (OR = 2.56, 95% CI = 1.38-4.77), past history of stroke (OR = 3.63, 95% CI = 2.09-6.31), and cognitive impairment (OR =2.83, 95% CI =1.96-4.09). Living alone (OR = 3.56, 95% CI = 1.48-8.57), living with children (OR = 1.97, 95% CI = 1.02-3.78), and past history of gouty arthritis (OR =2.46, 95% CI = 1.27-4.79) were significantly associated with depression in women, but not in men. CONCLUSION: Women have a higher prevalence of geriatric depression than men. Our data support the differential exposure hypothesis and the differential vulnerability hypothesis of sex difference in geriatric depression.


Subject(s)
Depression/epidemiology , Geriatric Assessment/statistics & numerical data , Age Distribution , Age Factors , Aged , Aged, 80 and over , Chronic Disease/epidemiology , Cross-Sectional Studies , Data Collection , Female , Humans , Male , Neuropsychological Tests , Prevalence , Psychiatric Status Rating Scales , Psychometrics , Residence Characteristics , Risk Factors , Sex Characteristics , Socioeconomic Factors , Taiwan/epidemiology
9.
Neuropsychobiology ; 48(1): 5-9, 2003.
Article in English | MEDLINE | ID: mdl-12886033

ABSTRACT

The human serotonin transporter (5-HTT) gene is an important candidate for the pathogenesis of mood disorders. Associations have been reported between a variable-number tandem-repeat polymorphism in intron 2 of the serotonin transporter gene (5-HTTVNTR) and mood disorders in a number of studies of Western and Chinese populations. However, no such relationships have been determined in other analogous research. To replicate these positive findings in a Chinese population and to determine the association between onset age of bipolar disorder and 5-HTTVNTR, we investigated the prevalence of this polymorphism in an independent Chinese population (83 bipolar disorder patients, 77 major depressive disorder patients and 169 controls), demonstrating no significant association between the 5-HTTVNTR polymorphism and mood disorders or age at onset. Further, no association was demonstrated between this polymorphism and suicidal history in mood disorder patients. These negative findings suggest that 5-HTTVNTR does not play a major role in the pathogenesis of mood disorder in Chinese populations.


Subject(s)
Age of Onset , Carrier Proteins/genetics , Membrane Glycoproteins/genetics , Membrane Transport Proteins , Minisatellite Repeats/genetics , Mood Disorders/genetics , Nerve Tissue Proteins , Polymorphism, Genetic , Suicide, Attempted , Adult , Asian People/genetics , Case-Control Studies , Diagnostic and Statistical Manual of Mental Disorders , Female , Gene Frequency , Genotype , Humans , Male , Middle Aged , Mood Disorders/classification , Mood Disorders/epidemiology , Mood Disorders/psychology , Reverse Transcriptase Polymerase Chain Reaction , Serotonin Plasma Membrane Transport Proteins
SELECTION OF CITATIONS
SEARCH DETAIL